Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 8
2006 5
2007 8
2008 6
2009 11
2010 8
2011 12
2012 8
2013 9
2014 9
2015 13
2016 16
2017 18
2018 20
2019 20
2020 29
2021 48
2022 36
2023 35
2024 35
2025 48
2026 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

386 results

Results by year

Filters applied: . Clear all
Page 1
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, Shah SJ, Voors AA, Zannad F, Abidin IZ, Alcocer-Gamba MA, Atherton JJ, Bauersachs J, Chang-Sheng M, Chiang CE, Chioncel O, Chopra V, Comin-Colet J, Filippatos G, Fonseca C, Gajos G, Goland S, Goncalvesova E, Kang S, Katova T, Kosiborod MN, Latkovskis G, Lee AP, Linssen GCM, Llamas-Esperón G, Mareev V, Martinez FA, Melenovský V, Merkely B, Nodari S, Petrie MC, Saldarriaga CI, Saraiva JFK, Sato N, Schou M, Sharma K, Troughton R, Udell JA, Ukkonen H, Vardeny O, Verma S, von Lewinski D, Voronkov L, Yilmaz MB, Zieroth S, Lay-Flurrie J, van Gameren I, Amarante F, Kolkhof P, Viswanathan P; FINEARTS-HF Committees and Investigators. Solomon SD, et al. N Engl J Med. 2024 Oct 24;391(16):1475-1485. doi: 10.1056/NEJMoa2407107. Epub 2024 Sep 1. N Engl J Med. 2024. PMID: 39225278 Clinical Trial.
The primary outcome was a composite of total worsening heart failure events (with an event defined as a first or recurrent unplanned hospitalization or urgent visit for heart failure) and death from cardiovascular causes. The components of the primary outcome and safety we …
The primary outcome was a composite of total worsening heart failure events (with an event defined as a first or recurrent unplanned hospita …
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Felker GM, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, She L, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F; VICTOR Study Group. Butler J, et al. Lancet. 2025 Sep 27;406(10510):1341-1350. doi: 10.1016/S0140-6736(25)01665-4. Epub 2025 Aug 30. Lancet. 2025. PMID: 40897189 Clinical Trial.
The primary composite endpoint was time to cardiovascular death or heart failure hospitalisation. Efficacy endpoints were assessed in the intention-to-treat population. ...INTERPRETATION: Among patients with HFrEF and no recent worsening, vericiguat did not reduce the risk …
The primary composite endpoint was time to cardiovascular death or heart failure hospitalisation. Efficacy endpoints were assessed in …
Family single-cell atlases reveal pig pregnancy and fetal growth restriction critical cell types.
Cai L, Zhang Q, Yao T, Zou X, Xie L, Yang S, Xiao Y, Huang F, Peng Z, Yang J, Huang J, Jing Q, Ling Z, Zheng M, Qiao C, Wu J, Chen J, Jiang T, Liu Q, Liu M, Chen Z, Li J, Jiang H, Jiang H, Chen Z, Liao Y, Huang Y, Li L, Zhou Y, Zhang Z, Yin C, Ye Y, Yang H, Chen B, Wang Z, Gong H, Chen D, Huang C, Tong X, Zhou Z, Fu H, Sun Y, Sun X, Yan M, Wu L, Xiong S, Wang Y, Xie X, Zhou M, Liu X, Xie X, Wu F, Liu Z, Ge M, Xiong S, Li C, Shen T, Liu Y, Tang X, Chang X, Liu S, Yu C, Yu N, Hu Z, Cui D, Zhong J, Liu S, Hu J, Wen Y, Zhou W, Wei G, Lin S, Xiahou Y, Chen L, Li J, Liu R, Chen X, Shu Y, Chen F, Wei C, Hu X, Li Y, Hou Y, Zeng Q, Gao J, Su Y, Li J, Ma J, Guo Y, Chen C, Xiao S, Ai H, Zhang Z, Liu W, Yang Q, Xing Y, Rao L, Yang B, Huang L. Cai L, et al. Among authors: zhang q. Science. 2026 Mar 26;391(6792):eadu7265. doi: 10.1126/science.adu7265. Epub 2026 Mar 26. Science. 2026. PMID: 41886583
MiR-125 Family in Cardiovascular and Cerebrovascular Diseases.
Wang Y, Tan J, Wang L, Pei G, Cheng H, Zhang Q, Wang S, He C, Fu C, Wei Q. Wang Y, et al. Among authors: zhang q. Front Cell Dev Biol. 2021 Dec 2;9:799049. doi: 10.3389/fcell.2021.799049. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34926475 Free PMC article. Review.
A large amount of literature shows that the lack of miR-125 can cause abnormal development of the cardiovascular system in the embryonic period. At the same time, the miR-125 family participates in the occurrence and development of a variety of cardiovascular …
A large amount of literature shows that the lack of miR-125 can cause abnormal development of the cardiovascular system in the …
386 results